TFA Therapeutics (RAJAF) FCF Margin (2020 - 2023)
TFA Therapeutics (RAJAF) posted FCF Margin of 778.06% for Q4 2023, up 59.9% on a QoQ basis from 1940.1% in Q4 2022, and up 116204.0% year-over-year from N/an in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) FCF Margin (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported FCF Margin for 3 years, with the latest figure at 778.06% in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.60 Bn | 69.23 Bn | 3.30 Bn | 16.17% |
| 2 | Kenvue | 34.20 Bn | 33.09 Bn | 2.30 Bn | 15.78% |
| 3 | Kimberly Clark | 32.87 Bn | 31.92 Bn | 1.60 Bn | 13.27% |
| 4 | Bath & Body Works | 3.77 Bn | 2.97 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | - | - |
| 6 | Perrigo | 2.00 Bn | 1.60 Bn | 313.90 Mn | 6.68% |
| 7 | Herbalife | 1.28 Bn | 913.80 Mn | 1.03 Bn | 1.63% |
| 8 | Edgewell Personal Care | 1.25 Bn | 854.28 Mn | 242.50 Mn | 18.08% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 599.63 Mn | 493.73 Mn | 40.36 Mn | 37.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -778.06% |
| Dec 31, 2022 | -1,940.10% |
| Dec 31, 2020 | -922.13% |